Controversy still swirls around FDA user fees: since 1992, the prescription drug user fee act and reauthorizations have sped up new drug approvals--but does speed equal safety?
作者信息
Ullman Kurt
出版信息
Ann Neurol. 2013 Nov;74(5):A10-1. doi: 10.1002/ana.24045.